MedPath

PHARMAZZ INDIA PRIVATE LIMITED

🇮🇳India
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

20

Active:2
Completed:10

Trial Phases

4 Phases

Phase 1:2
Phase 2:10
Phase 3:4
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (20 trials with phase data)• Click on a phase to view related trials

Phase 2
10 (50.0%)
Phase 3
4 (20.0%)
Phase 4
4 (20.0%)
Phase 1
2 (10.0%)
No trials found

News

Sun Pharma Increases Investment in US-Based Pharmazz to Expand Specialty Therapeutics Portfolio

Sun Pharma has signed an agreement to invest up to $25 million in US-based Pharmazz, increasing its stake to approximately 22.7% on a fully diluted basis.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.